LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,043,147 | +48.3% | 17,409 | +78.4% | 0.00% | 0.0% |
| Q2 2023 | $703,480 | +234.7% | 9,757 | +241.5% | 0.00% | – |
| Q1 2023 | $210,161 | -12.8% | 2,857 | -20.8% | 0.00% | – |
| Q4 2022 | $241,081 | -89.8% | 3,609 | -86.8% | 0.00% | -100.0% |
| Q3 2022 | $2,354,000 | -13.9% | 27,345 | -10.7% | 0.00% | 0.0% |
| Q2 2022 | $2,734,000 | -20.4% | 30,638 | -9.5% | 0.00% | 0.0% |
| Q1 2022 | $3,434,000 | -16.4% | 33,869 | +27.4% | 0.00% | -25.0% |
| Q4 2021 | $4,107,000 | -11.5% | 26,586 | -20.2% | 0.00% | -20.0% |
| Q3 2021 | $4,642,000 | +1.7% | 33,314 | -4.3% | 0.01% | +25.0% |
| Q2 2021 | $4,565,000 | -22.5% | 34,794 | -10.0% | 0.00% | -33.3% |
| Q1 2021 | $5,893,000 | +902.2% | 38,658 | +554.2% | 0.01% | +500.0% |
| Q4 2020 | $588,000 | -97.6% | 5,909 | -97.7% | 0.00% | -96.9% |
| Q3 2020 | $24,563,000 | -19.5% | 257,691 | -5.5% | 0.03% | -22.0% |
| Q2 2020 | $30,516,000 | -28.7% | 272,831 | -53.6% | 0.04% | +13.9% |
| Q1 2020 | $42,788,000 | +35.7% | 588,396 | +94.6% | 0.04% | -5.3% |
| Q4 2019 | $31,531,000 | -22.3% | 302,333 | -25.9% | 0.04% | -26.9% |
| Q3 2019 | $40,588,000 | -39.4% | 407,753 | -30.5% | 0.05% | -61.5% |
| Q2 2019 | $66,987,000 | -18.7% | 586,835 | -10.5% | 0.14% | -28.2% |
| Q1 2019 | $82,428,000 | +29.3% | 655,690 | +39.6% | 0.19% | +17.5% |
| Q4 2018 | $63,725,000 | -47.0% | 469,600 | +7.2% | 0.16% | -35.5% |
| Q3 2018 | $120,260,000 | +8.0% | 438,125 | -18.5% | 0.25% | +4.6% |
| Q2 2018 | $111,324,000 | +32.1% | 537,355 | +5.3% | 0.24% | +28.8% |
| Q1 2018 | $84,277,000 | +16.6% | 510,280 | -3.3% | 0.18% | +21.1% |
| Q4 2017 | $72,273,000 | -19.7% | 527,812 | -20.2% | 0.15% | -24.8% |
| Q3 2017 | $90,032,000 | +9.2% | 661,270 | -2.6% | 0.20% | +4.7% |
| Q2 2017 | $82,424,000 | +14.2% | 678,945 | -0.5% | 0.19% | +12.2% |
| Q1 2017 | $72,205,000 | -26.4% | 682,210 | -29.3% | 0.17% | -30.4% |
| Q4 2016 | $98,081,000 | +2.2% | 965,262 | +2.7% | 0.25% | -8.2% |
| Q3 2016 | $95,949,000 | +145277.3% | 940,127 | +168987.6% | 0.27% | – |
| Q2 2016 | $66,000 | +94.1% | 556 | +76.5% | 0.00% | – |
| Q1 2016 | $34,000 | -44.3% | 315 | -44.0% | 0.00% | – |
| Q4 2015 | $61,000 | +22.0% | 563 | -2.9% | 0.00% | – |
| Q3 2015 | $50,000 | -23.1% | 580 | -10.8% | 0.00% | – |
| Q2 2015 | $65,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |